Strata Critical Medical, Inc.SRTAEarnings & Financial Report
Strata Critical Medical, Inc. is a medical technology firm designing, producing and distributing disposable medical products for critical care, anesthesia and surgical use cases. It serves healthcare providers across North America and some European markets, focusing on improving patient safety and clinical efficiency.
Revenue
$70.8M
Gross Profit
$17.7M
Operating Profit
$-5.0M
Net Profit
$-3.7M
Gross Margin
25.1%
Operating Margin
-7.0%
Net Margin
-5.3%
YoY Growth
4.2%
EPS
$-0.05
Strata Critical Medical, Inc. Q2 FY2025 Financial Summary
Strata Critical Medical, Inc. reported revenue of $70.8M (up 4.2% YoY) for Q2 FY2025, with a net profit of $-3.7M (up 67.0% YoY) (-5.3% margin). Cost of goods sold was $53.1M, operating expenses totaled $22.7M.
Key Financial Metrics
| Total Revenue | $70.8M |
|---|---|
| Net Profit | $-3.7M |
| Gross Margin | 25.1% |
| Operating Margin | -7.0% |
| Report Period | Q2 FY2025 |
Revenue Breakdown
Strata Critical Medical, Inc. Q2 FY2025 revenue of $70.8M breaks down across 3 segments, led by Medi Mobility Organ Transport And Jet at $45.1M (63.7% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Medi Mobility Organ Transport And Jet | $45.1M | 63.7% |
| Short Distance | $17.2M | 24.3% |
| Jet And Other | $8.5M | 12.0% |
Strata Critical Medical, Inc. Revenue by Segment — Quarterly Trend
Strata Critical Medical, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Medi Mobility Organ Transport And Jet and Short Distance) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Medi Mobility Organ Transport And Jet | — | — | $45.1M | $35.9M |
| Short Distance | — | — | $17.2M | — |
| Jet And Other | — | — | $8.5M | — |
Strata Critical Medical, Inc. Annual Revenue by Year
Strata Critical Medical, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $197.1M).
| Year | Annual Revenue |
|---|---|
| 2025 | $197.1M |
| 2024 | $146.8M |
| 2023 | $225.2M |
| 2022 | $146.1M |
Strata Critical Medical, Inc. Quarterly Revenue & Net Profit History
Strata Critical Medical, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $22.7M | +361.2% | N/A | N/A |
| Q3 FY2025 | $49.3M | +36.7% | $57.4M | 116.5% |
| Q2 FY2025 | $70.8M | +4.2% | $-3.7M | -5.3% |
| Q1 FY2025 | $54.3M | +5.4% | $-3.5M | -6.4% |
| Q4 FY2024 | $-8.7M | -118.3% | N/A | N/A |
| Q3 FY2024 | $36.1M | -49.5% | $-2.0M | -5.4% |
| Q2 FY2024 | $67.9M | +11.4% | $-11.3M | -16.7% |
| Q1 FY2024 | $51.5M | +13.8% | $-4.2M | -8.2% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $51.5M | $67.9M | $36.1M | $-8.7M | $54.3M | $70.8M | $49.3M | $22.7M |
| YoY Growth | 13.8% | 11.4% | -49.5% | -118.3% | 5.4% | 4.2% | 36.7% | 361.2% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $282.8M | $280.3M | $282.9M | $256.7M | $250.6M | $257.9M | $335.1M | $325.5M |
| Liabilities | $46.2M | $50.9M | $49.4M | $34.7M | $30.8M | $34.8M | $52.1M | $46.4M |
| Equity | $236.6M | $229.4M | $233.5M | $221.9M | $219.7M | $223.1M | $283.0M | $279.1M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-15.6M | $8.4M | $6.4M | $-1.8M | $-246000 | $-3.1M | $-37.3M | $-8.3M |